Design and semisynthesis of novel fredericamycin A derivatives with an improved antitumor profile |
| |
| Authors: | Abel Ulrich Simon Werner Eckard Peter Hansske Friedrich G |
| |
| Affiliation: | Santhera Pharmaceuticals, Im Neuenheimer Feld 518-519, 69120 Heidelberg, Germany. |
| |
| Abstract: | We report the design, semisynthesis, and biological activity of a series of fredericamycin (1) derivatives. Within this series compound 1e combines low nanomolar cytotoxic potency in vitro, increased tumor cell line selectivity, and in vivo activity in a human xenograft model. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect PubMed 等数据库收录！ |
|
